Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

CHB patients with metabolic dysfunction and/or MASLD are at significant risk of HCC. The PAGE-B score can be used to stratify HCC risk in this population, with negligible 5-year HCC incidence in those without cirrhosis and low PAGE-B scores. However, caution should be exercised in patients with cirrhosis in whom HCC risk remains significant even among those with a low PAGE-B score.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-09-09
DOI
https://doi.org/10.1111/apt.70360
Citations
4
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

R. Bart Takkenberg, Robert A. de Man, Hans Blokzijl, Lesley A. Patmore et al.
4 citations
Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and Treatment
5.42
article

Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

R. Bart Takkenberg, Robert A. de Man, Hans Blokzijl, Lesley A. Patmore, Ivana Carey, Bettina E. Hansen, Keyur Patel, Joep de Bruijne, Douwe F. Postma, Jordan J. Feld, Faydra I. Lieveld, Marı́a Buti, Eva van Oorschot, Pieter Honkoop, Milan J. Sonneveld, Kosh Agarwal, Mai Kilany, Özgür M. Koc, Mark A. A. Claassen, Willem Pieter Brouwer, Marc van der Valk, Matthijs Kramer, Harry L.A. Janssen
article en
4 citations

Abstract

CHB patients with metabolic dysfunction and/or MASLD are at significant risk of HCC. The PAGE-B score can be used to stratify HCC risk in this population, with negligible 5-year HCC incidence in those without cirrhosis and low PAGE-B scores. However, caution should be exercised in patients with cirrhosis in whom HCC risk remains significant even among those with a low PAGE-B score.

Alimentary Pharmacology & TherapeuticsVol. 63(3)
Hebron University (PS), University Medical Center Groningen (NL), Toronto General Hospital (CA), Erasmus MC (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Albert Schweitzer Ziekenhuis (NL), Netherlands Center for Occupational Diseases (NL), Stichting HIV Monitoring (NL), Vall d'Hebron Hospital Universitari (ES), Amsterdam University Medical Centers (NL), Rijnstate Hospital (NL), King's College Hospital (GB), Maastro Clinic (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)
Gilead Sciences
Openalex Percentile: Top 4%
Liver Disease Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.